Thureau, S., Raimbourg, J., Pourel, N., Curcio, H., Wislez, M., Guisier, F., Martin, E., Khalifa, J., Amour, E., Berndt, C., Langlais, A., Morin, F., Westeel, V., Cortot, A. B. (2026). IFCT-2401 SPORADIC trial: Integrating cemiplimab to sequential hypofractionated chemoradiotherapy for unfit or elderly patients with unresectable stage III non–small cell lung cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps8128